A framework for extremely multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity
T cell receptor (TCR) antigen-specific recognition is important for the adaptive immune system. Nevertheless, constructing a TCR-antigen interplay map has been difficult because of the staggering range of TCRs and antigens. Accordingly, extremely multiplexed dextramer-TCR binding assays have been just lately developed, however the utility of the following giant datasets is restricted by the shortage of sturdy computational strategies for normalization and interpretation.
Right here, we current a computational framework comprising a novel technique, ICON (Integrative COntext-specific Normalization), for figuring out dependable TCR-pMHC (peptide-major histocompatibility complicated) interactions and a neural network-based classifier TCRAI that outperforms different state-of-the-art strategies for TCR-antigen specificity prediction. We additional demonstrated that by combining ICON and TCRAI, we’re capable of uncover novel subgroups of TCRs that bind to a given pMHC through totally different mechanisms. Our framework facilitates the identification and understanding of TCR-antigen-specific interactions for fundamental immunological analysis and medical immune monitoring.
Quantifying persistence within the T-cell signaling community utilizing an optically controllable antigen receptor
T cells discriminate between wholesome and contaminated cells with outstanding sensitivity when mounting an immune response, which is hypothesized to rely on T cells combining stimuli from a number of antigen-presenting cell interactions right into a stronger response. To quantify the capability for T cells to perform this, we now have developed an antigen receptor that’s optically tunable inside cell conjugates, offering management over the length, and depth of intracellular T-cell signaling.
We observe restricted persistence inside the T-cell intracellular community on disruption of receptor enter, with indicators dissipating solely in ~15 min, and straight present sustained proximal receptor signaling is required to keep up gene transcription. T cells thus primarily accumulate the outputs of gene expression slightly than combine discrete intracellular indicators. Engineering optical management in a clinically related chimeric antigen receptor (CAR), we present that this restricted sign persistence will be exploited to extend CAR-T cell activation threefold utilizing pulsatile stimulation. Our outcomes are prone to apply extra typically to the signaling dynamics of different mobile networks.
Tumor rejection properties of gp100 209-specific T cells correlate with T cell receptor binding affinity in direction of the wild sort slightly than anchor-modified antigen
Though there are exceptions and outliers, T cell useful responses typically correlate with the affinity of a TCR for a peptide/MHC complicated. In a single just lately described outlier case, essentially the most promising medical candidate in a sequence of TCRs particular for the gp100209 melanoma antigen certain with the weakest resolution affinity and produced the least quantity of cytokine in vitro. Hypotheses for this outlier conduct included uncommon cytokine expression patterns arising from an atypical TCR binding geometry. Learning this occasion in additional element, we discovered right here that outlier conduct is attributable to not uncommon cytokine patterns or TCR binding, however the usage of a place 2 anchor-modified peptide variant in in vitro experiments as an alternative of the wild sort antigen that’s current in vivo.
Though the anchor-modified variant has been extensively utilized in fundamental and medical immunology as a surrogate for the wild sort peptide, prior work has proven that TCRs can clearly distinguish between the 2. We present that when this differential recognition is accounted for, the useful properties of gp100209-specific TCRs observe with their affinity in direction of the peptide/MHC complicated. Past demonstrating the correlates with T cell operate for a clinically related TCR, our outcomes present necessary concerns for choice of TCRs for immunotherapy and the usage of modified peptides in immunology.
EBAG9 Peptide |
|||
| 45-515P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: EBAG9 / RCAS1 Peptide |
|||
EBAG9 Antibody |
|||
| ABD6703 | Lifescience Market | 100 ug | EUR 525.6 |
EBAG9 siRNA |
|||
| 20-abx901624 | Abbexa |
|
|
EBAG9 siRNA |
|||
| 20-abx914879 | Abbexa |
|
|
EBAG9 siRNA |
|||
| 20-abx914880 | Abbexa |
|
|
EBAG9 antibody |
|||
| 70R-9916 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal EBAG9 antibody |
|||
EBAG9 Antibody |
|||
| DF6703 | Affbiotech | 200ul | EUR 420 |
EBAG9 Antibody |
|||
| 1-CSB-PA007355GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against EBAG9. Recognizes EBAG9 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
EBAG9 Antibody |
|||
| R31790 | NSJ Bioreagents | 100 ug | EUR 419 |
EBAG9 Antibody |
|||
| R34393-100UG | NSJ Bioreagents | 100 ug | EUR 399 |
CMV (Cytomegalovirus Antibody IgG) ELISA test |
|||
| 28 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgG) |
|||
ALS-Style Pucks (28) - Bulk Pricing Options |
|||
| M-CP-111-035-28 | MiTeGen | 14 PUCKS | EUR 8480 |
|
Description: ALS-Style Pucks (28) - Bulk Pricing Options |
|||
EBAG9 protein (His tag) |
|||
| 80R-1093 | Fitzgerald | 100 ug | EUR 268.8 |
|
Description: Purified recombinant Human EBAG9 protein |
|||
Human EBAG9 Antibody |
|||
| 32605-05111 | AssayPro | 150 ug | EUR 313.2 |
EBAG9 Blocking Peptide |
|||
| 33R-2039 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EBAG9 antibody, catalog no. 70R-9916 |
|||
EBAG9 Rabbit pAb |
|||
| A8385-100ul | Abclonal | 100 ul | EUR 369.6 |
EBAG9 Rabbit pAb |
|||
| A8385-200ul | Abclonal | 200 ul | EUR 550.8 |
EBAG9 Rabbit pAb |
|||
| A8385-20ul | Abclonal | 20 ul | Ask for price |
EBAG9 Rabbit pAb |
|||
| A8385-50ul | Abclonal | 50 ul | Ask for price |
EBAG9 Rabbit pAb |
|||
| A1935-100ul | Abclonal | 100 ul | EUR 369.6 |
EBAG9 Rabbit pAb |
|||
| A1935-200ul | Abclonal | 200 ul | EUR 550.8 |
EBAG9 Rabbit pAb |
|||
| A1935-20ul | Abclonal | 20 ul | EUR 219.6 |
EBAG9 Rabbit pAb |
|||
| A1935-50ul | Abclonal | 50 ul | EUR 267.6 |
EBAG9 Blocking Peptide |
|||
| DF6703-BP | Affbiotech | 1mg | EUR 234 |
EBAG9 Conjugated Antibody |
|||
| C38323 | SAB | 100ul | EUR 476.4 |
EBAG9 cloning plasmid |
|||
| CSB-CL007355HU1-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
EBAG9 cloning plasmid |
|||
| CSB-CL007355HU2-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
Anti-EBAG9 Antibody |
|||
| PB9553 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-EBAG9 antibody |
|||
| STJ110683 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
Anti-EBAG9 antibody |
|||
| STJ23462 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
Anti-EBAG9 (4A10) |
|||
| YF-MA16699 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to EBAG9 |
|||
pCMV-SPORT6-EBAG9 |
|||
| PVT13493 | Lifescience Market | 2 ug | EUR 469.2 |
RNU6-28 Recombinant Protein (Human) |
|||
| RP089073 | ABM | 100 ug | Ask for price |
Recombinant HPV-28 E1 Protein |
|||
| VAng-Wyb3131-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Replication protein E1, recombinant protein. |
|||
Recombinant HPV-28 L1 Protein |
|||
| VAng-Wyb3136-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Major capsid protein L1, recombinant protein. |
|||
Polyclonal EBAG9 Antibody (Center) |
|||
| APR06938G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal EBAG9 Antibody (Center) |
|||
| APR04492G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
Human EBAG9 shRNA Plasmid |
|||
| 20-abx956064 | Abbexa |
|
|
Mouse EBAG9 shRNA Plasmid |
|||
| 20-abx974569 | Abbexa |
|
|
Rat EBAG9 shRNA Plasmid |
|||
| 20-abx989010 | Abbexa |
|
|
Anti-EBAG9 / RCAS1 antibody |
|||
| STJ70947 | St John's Laboratory | 100 µg | EUR 430.8 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-100ug |
|||
| QP5959-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-10ug |
|||
| QP5959-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-1mg |
|||
| QP5959-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-200ug |
|||
| QP5959-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-500ug |
|||
| QP5959-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-50ug |
|||
| QP5959-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
IL-28, human recombinant |
|||
| 4978-1000 | Biovision | EUR 6244.8 | |
IL-28, human recombinant |
|||
| 4978-20 | Biovision | EUR 352.8 | |
Matrix Metalloproteinase-28 (Recombinant) |
|||
| 20-abx073425 | Abbexa |
|
|
Recombinant Keratin 28 (KRT28) |
|||
| 4-RPS214Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Keratin 28 expressed in: E.coli |
|||
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06871 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06872 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06873 | CHI Scientific | 1mg | Ask for price |
Human EBAG9 Antibody (Biotin Conjugate) |
|||
| 32605-05121 | AssayPro | 150 ug | EUR 442.8 |
EBAG9 ELISA Kit (Human) (OKEH05822) |
|||
| OKEH05822 | Aviva Systems Biology | 96 Wells | EUR 794.4 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.39U/L |
|||
Ebag9 ORF Vector (Rat) (pORF) |
|||
| ORF066324 | ABM | 1.0 ug DNA | EUR 607.2 |
EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003366 | ABM | 1.0 ug DNA | EUR 114 |
EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003367 | ABM | 1.0 ug DNA | EUR 114 |
Ebag9 ORF Vector (Mouse) (pORF) |
|||
| ORF043560 | ABM | 1.0 ug DNA | EUR 607.2 |
EBAG9 ELISA Kit (Human) (OKCA02302) |
|||
| OKCA02302 | Aviva Systems Biology | 96 Wells | EUR 1116 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: 0.195 U/mL. |
|||
EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013461 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013462 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013463 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013464 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013465 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013466 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013467 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013468 | ABM | 500 ng | EUR 394.8 |
EBAG9 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV174238 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV174239 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV174240 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV174241 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPB-C-His) |
|||
| PV265294 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPB-N-His) |
|||
| PV265295 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV265296 | ABM | 500 ng | EUR 723.6 |
EBAG9 Protein Vector (Rat) (pPM-C-His) |
|||
| PV265297 | ABM | 500 ng | EUR 723.6 |
Insulin R / CD220 (28-944) Recombinant Protein |
|||
| 11-371 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: Insulin receptor (INSR) is also known as CD antigen CD220, which can be cleaved into the following 2 chains: Insulin receptor subunit alpha and Insulin receptor subunit beta. INSR is a tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain. Forms a hybrid receptor with IGF1R, the hybrid is a tetramer consisting of 1 alpha chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of IGF1R. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short of INSR has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, INSR binds IGF1. |
|||
PRSS28 Protease Serine 28 Mouse Recombinant Protein |
|||
| PROTQ924N9 | BosterBio | Regular: 5ug | EUR 380.4 |
|
Description: PRSS28 Mouse Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 256 amino acids (27-274a.a.) and having a molecular mass of 28.7kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa)._x000D_PRSS28 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
|||
MMP28 Matrix Metalloproteinase-28 Human Recombinant Protein |
|||
| PROTQ9H239 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: MMP28 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 421 amino acids (123-520a.a) and having a molecular mass of 47.3kDa. MMP28 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-100g | Creative Biolabs | 100 µg | EUR 8704.8 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-50g | Creative Biolabs | 50 µg | EUR 5718 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-100g | Creative Biolabs | 100 µg | EUR 1380 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-1mg | Creative Biolabs | 1 mg | EUR 4695.6 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-500g | Creative Biolabs | 500 µg | EUR 3195.6 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-1mg | Creative Biolabs | 1 mg | EUR 4068 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-200g | Creative Biolabs | 200 µg | EUR 1644 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-500g | Creative Biolabs | 500 µg | EUR 2667.6 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-1mg | Creative Biolabs | 1 mg | EUR 7022.4 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-500g | Creative Biolabs | 500 µg | EUR 4299.6 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-500g | Creative Biolabs | 500 µg | EUR 7698 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-50g | Creative Biolabs | 50 µg | EUR 1495.2 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-100g | Creative Biolabs | 100 µg | EUR 1215.6 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-1mg | Creative Biolabs | 1 mg | EUR 7682.4 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-20g | Creative Biolabs | 20 µg | EUR 712.8 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-50g | Creative Biolabs | 50 µg | EUR 1215.6 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3092.4 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2096.4 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1436.4 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Bulk Beads |
|||
| D1133-28 | Benchmark Scientific | 1 PC | EUR 112.45 |
Prefilled 2.0ml tubes |
|||
| D1033-28 | Benchmark Scientific | 1 PC | EUR 215.81 |
Prefilled 5.0ml tubes |
|||
| D1034-28 | Benchmark Scientific | 1 PC | EUR 285.76 |
Anti-Histone H3 pan Rabbit Monoclonal Antibody, Clone#RM188 |
|||
| M06819-28 | BosterBio | 100ug | EUR 561.6 |
|
Description: Anti-Histone H3 pan Rabbit Monoclonal Antibody, Clone#RM188 tested in WB, ELISA, Multiplex, ICC, reactive to All Vertebrates |
|||
IL-17, Interleukin-17 IL-17A, human |
|||
| RC212-28 | Bio Basic | 5ug | EUR 125.26 |
TARC, CCL17, human |
|||
| RC315-28 | Bio Basic | 5ug | EUR 125.26 |
TARC, CCL17, murine (mouse) |
|||
| RC335-28 | Bio Basic | 5ug | EUR 125.26 |
VCC-1, CXCL17, rat |
|||
| RC352-28 | Bio Basic | 2ug | EUR 125.26 |
VPS28 Vacuolar Protein Sorting 28 Human Recombinant Protein |
|||
| PROTQ9UK41 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: VPS28 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 221 amino acids (1-221 a.a.) and having a molecular mass of 25.4kDa.;The VPS28 is purified by proprietary chromatographic techniques. |
|||
Somatostatin-28 |
|||
| 5-01950 | CHI Scientific | 0.4 x 5mg | Ask for price |
SMER 28 |
|||
| B7637-10 | ApexBio | 10 mg | EUR 226.8 |
|
Description: IC50: N/ASMER 28 is a new small-molecule enhancer of the cytostatic effects. |
|||
SMER 28 |
|||
| B7637-50 | ApexBio | 50 mg | EUR 762 |
|
Description: IC50: N/ASMER 28 is a new small-molecule enhancer of the cytostatic effects. |
|||
WRG-28 |
|||
| HY-114169 | MedChemExpress | 1mg | EUR 129.6 |
Somatostatin-28 |
|||
| H-4955.0500 | Bachem | 0.5mg | EUR 471.6 |
|
Description: Sum Formula: C137H207N41O39S3; CAS# [73032-94-7] net |
|||
Somatostatin-28 |
|||
| H-4955.1000 | Bachem | 1.0mg | EUR 835.2 |
|
Description: Sum Formula: C137H207N41O39S3; CAS# [73032-94-7] net |
|||
28-Deoxonimbolide |
|||
| TBZ1212 | ChemNorm | unit | Ask for price |
Human EBAG9 AssayLite Antibody (FITC Conjugate) |
|||
| 32605-05141 | AssayPro | 150 ug | EUR 513.6 |
Human EBAG9 AssayLite Antibody (RPE Conjugate) |
|||
| 32605-05151 | AssayPro | 150 ug | EUR 513.6 |
Human EBAG9 AssayLite Antibody (APC Conjugate) |
|||
| 32605-05161 | AssayPro | 150 ug | EUR 513.6 |
Human EBAG9 AssayLite Antibody (PerCP Conjugate) |
|||
| 32605-05171 | AssayPro | 150 ug | EUR 565.2 |
Polyclonal Goat Anti-EBAG9 / RCAS1 Antibody |
|||
| APG00095G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-EBAG9 / RCAS1 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal EBAG9 / RCAS1 Antibody (C-Terminus) |
|||
| APG01031G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human EBAG9 / RCAS1 (C-Terminus). This antibody is tested and proven to work in the following applications: |
|||
Ebag9 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7421201 | ABM | 3 x 1.0 ug | EUR 406.8 |
EBAG9 sgRNA CRISPR Lentivector set (Human) |
|||
| K0649501 | ABM | 3 x 1.0 ug | EUR 406.8 |
Ebag9 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4445001 | ABM | 3 x 1.0 ug | EUR 406.8 |
Vacuolar Protein Sorting 28 Protein |
|||
| 20-abx260470 | Abbexa |
|
|
Human Matrix Metalloproteinase-28 (MMP-28) Antibody |
|||
| 31369-05111 | AssayPro | 150 ug | EUR 313.2 |
Mouse Interleukin 28(IL-28) ELISA Kit |
|||
| CSB-E15986m-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Interleukin 28 (IL-28) in samples from serum, plasma, cell culture supernates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Mouse Interleukin 28(IL-28) ELISA Kit |
|||
| 1-CSB-E15986m | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse Interleukin 28(IL-28) in samples from serum, plasma, cell culture supernates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
TRIM28 Tripartite Motif Containing 28 Human Recombinant Protein |
|||
| PROTQ13263 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: TRIM28 Human Recombinant produced in E. Coli is a single polypeptide chain containing 460 amino acids (366-802) and having a molecular mass of 48.7 kDa.;TRIM28 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant Clostridium Sordellii Sialidase Protein (aa 28-404) |
|||
| VAng-Lsx01506-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5508 |
|
Description: Clostridium Sordellii Sialidase, recombinant protein. |
|||
Recombinant Clostridium Sordellii Sialidase Protein (aa 28-404) |
|||
| VAng-Lsx01506-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3907.2 |
|
Description: Clostridium Sordellii Sialidase, recombinant protein. |
|||
Recombinant Clostridium Sordellii Sialidase Protein (aa 28-404) |
|||
| VAng-Lsx01506-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2671.2 |
|
Description: Clostridium Sordellii Sialidase, recombinant protein. |
|||
Recombinant Human ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2951Lsx-1mg | Creative Biolabs | 1 mg | EUR 2997.6 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2951Lsx-200g | Creative Biolabs | 200 µg | EUR 1099.2 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2951Lsx-500g | Creative Biolabs | 500 µg | EUR 2040 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-526) [Fc] |
|||
| VAng-2953Lsx-10g | Creative Biolabs | 10 µg | EUR 390 |
|
Description: Recombinant Human ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-526) [Fc] |
|||
| VAng-2953Lsx-50g | Creative Biolabs | 50 µg | EUR 621.6 |
|
Description: Recombinant Human ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q13740) |
|||
Recombinant Rat ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2954Lsx-1mg | Creative Biolabs | 1 mg | EUR 3210 |
|
Description: Recombinant Rat ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2954Lsx-200g | Creative Biolabs | 200 µg | EUR 1182 |
|
Description: Recombinant Rat ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-527) [His] |
|||
| VAng-2954Lsx-500g | Creative Biolabs | 500 µg | EUR 2188.8 |
|
Description: Recombinant Rat ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Yeast) |
|||
| VAng-3127Lsx-1mg | Creative Biolabs | 1 mg | EUR 7186.8 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Yeast. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Yeast) |
|||
| VAng-3127Lsx-500g | Creative Biolabs | 500 µg | EUR 4546.8 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Yeast. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Yeast) |
|||
| VAng-3127Lsx-50g | Creative Biolabs | 50 µg | EUR 2997.6 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Yeast. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Baculovirus) |
|||
| VAng-3128Lsx-100g | Creative Biolabs | 100 µg | EUR 5388 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Baculovirus. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Baculovirus) |
|||
| VAng-3128Lsx-500g | Creative Biolabs | 500 µg | EUR 6988.8 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Baculovirus. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) (Baculovirus) |
|||
| VAng-3128Lsx-50g | Creative Biolabs | 50 µg | EUR 3754.8 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in Baculovirus. (Uniprot ID: Q9BY76) |
|||
Recombinant Human ANGPTL4 Protein (aa 28-403) [GST] |
|||
| VAng-3138Lsx-50g | Creative Biolabs | 50 µg | EUR 984 |
|
Description: Recombinant Human Angiopoietin-like 4 protein, expressed in E. coli. (Uniprot ID: Q9BY76) |
|||
Recombinant Staphylococcus Aureus entB Protein (aa 28-266) |
|||
| VAng-Cr5729-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5751.6 |
|
Description: Staphylococcus Aureus Enterotoxin type B (entB), recombinant protein. |
|||
Recombinant Staphylococcus Aureus entB Protein (aa 28-266) |
|||
| VAng-Cr5729-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3657.6 |
|
Description: Staphylococcus Aureus Enterotoxin type B (entB), recombinant protein. |
|||
Recombinant Staphylococcus Aureus ENTC1 Protein (aa 28-266) |
|||
| VAng-Cr5730-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Staphylococcus Aureus Enterotoxin type C-1 (ENTC1), recombinant protein. |
|||
Recombinant Staphylococcus Aureus entC2 Protein (aa 28-266) |
|||
| VAng-Cr5731-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3195.6 |
|
Description: Staphylococcus Aureus Enterotoxin type C-2 (entC2), recombinant protein. |
|||
Recombinant Staphylococcus Aureus entC2 Protein (aa 28-266) |
|||
| VAng-Cr5731-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2172 |
|
Description: Staphylococcus Aureus Enterotoxin type C-2 (entC2), recombinant protein. |
|||
Recombinant Staphylococcus Aureus entE Protein (aa 28-257) |
|||
| VAng-Cr5733-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Staphylococcus Aureus Enterotoxin type E (entE), recombinant protein. |
|||
Recombinant Staphylococcus Aureus ssaA2 Protein (aa 28-267) |
|||
| VAng-Cr6465-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Staphylococcus Aureus (strain Mu50 / ATCC 700699) Staphylococcal secretory antigen ssaA2 (ssaA2), recombinant protein. |
|||
Recombinant Pseudomonas Aeruginosa falgL Protein (aa 28-367) |
|||
| VAng-Cr0486-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5493.6 |
|
Description: Pseudomonas Aeruginosa (strain PA7) alginate lyase (algL), recombinant protein. |
|||
Recombinant Pseudomonas Aeruginosa falgL Protein (aa 28-367) |
|||
| VAng-Cr0486-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3710.4 |
|
Description: Pseudomonas Aeruginosa (strain PA7) alginate lyase (algL), recombinant protein. |
|||
Recombinant Pseudomonas Aeruginosa falgL Protein (aa 28-367) |
|||
| VAng-Cr0486-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2530.8 |
|
Description: Pseudomonas Aeruginosa (strain PA7) alginate lyase (algL), recombinant protein. |
|||
Recombinant Pseudomonas Aeruginosa algL Protein (aa 28-367) |
|||
| VAng-Cr0750-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5493.6 |
|
Description: Pseudomonas Aeruginosa (strain LESB58) alginate lyase (algL), recombinant protein. |
|||
Recombinant Pseudomonas Aeruginosa algL Protein (aa 28-367) |
|||
| VAng-Cr0750-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3710.4 |
|
Description: Pseudomonas Aeruginosa (strain LESB58) alginate lyase (algL), recombinant protein. |
|||
Recombinant Pseudomonas Aeruginosa algL Protein (aa 28-367) |
|||
| VAng-Cr0750-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2530.8 |
|
Description: Pseudomonas Aeruginosa (strain LESB58) alginate lyase (algL), recombinant protein. |
|||
Proliferating cell nuclear antigen straight interacts with androgen receptor and enhances androgen receptor‑mediated signaling
Androgen receptor (AR) and/or its constitutively lively splicing variants (AR‑Vs), reminiscent of AR‑V7 and ARv567es, is required for prostate most cancers cell development and survival, and most cancers development. Proliferating cell nuclear antigen (PCNA) is preferentially overexpressed in all cancers and executes its capabilities by way of interplay with quite a few accomplice proteins. The goal of the current research was to research the potential position of PCNA within the regulation of AR exercise.
An equivalent consensus sequence of the PCNA‑interacting protein‑field (PIP‑field) was recognized on the N‑terminus of human, mouse and rat AR proteins. It was discovered that PCNA complexes with the total‑size AR (AR‑FL) and AR‑V7, which will be attenuated by the small molecule PIP‑field inhibitor, T2AA. PCNA additionally complexes with ARv567es and recombinant AR protein. The PCNA inhibitors, PCNA‑I1S and T2AA, inhibited AR transcriptional exercise and the expression of AR goal genes in LNCaP‑AI and 22Rv1 cells, however not in AR‑detrimental PC‑three cells. The knockdown of PCNA expression lowered dihydrotestosterone‑stimulated AR transcriptional exercise and abolished the inhibitory impact of PCNA‑I1S on AR exercise. The PCNA inhibitor, PCNA‑I1, exerted additive development inhibitory results with androgen deprivation and enzalutamide in cells expressing AR‑FL or AR‑FL/AR‑V7, however not in AR‑detrimental PC‑three cells.
Lastly, R9‑AR‑PIP, a small peptide mimicking AR PIP‑field, was discovered to bind to GFP‑PCNA at Okd of two.73 µM and inhibit the expression of AR goal genes, AR transcriptional exercise and the expansion of AR‑expressing cells. On the entire, these information strongly recommend that AR is a PCNA accomplice protein and interacts with PCNA through the PIP‑field and that focusing on the PCNA‑AR interplay might characterize an progressive and selective therapeutic technique towards prostate most cancers, notably castration‑resistant prostate cancers overexpressing constitutively lively AR‑Vs.
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells successfully remove human glioblastoma
Targets: The rising success of Chimeric Antigen Receptor (CAR) T cell remedy in haematological malignancies is reinvigorating its software in lots of different most cancers varieties and with renewed concentrate on its software to strong tumors. We current a novel CAR towards glioblastoma, an aggressive, malignant glioma, with a dismal survival charge for which therapy choices have remained unchanged for over a decade.
Strategies: We use the human Retained Show (ReD) antibody platform (Myrio Therapeutics) to establish a novel single-chain variable fragment (scFv) that recognises epidermal development issue receptor mutant variant III (EGFRvIII), a typical and tumor-specific mutation present in glioblastoma. We use each in vitro useful assays and an in vivo orthotopic xenograft mannequin of glioblastoma to look at the operate of our novel CAR, known as GCT02, focused utilizing murine CAR T cells.
Outcomes: Our EGFRvIII-specific scFv was discovered to be of a lot increased affinity than reported comparators reverse-engineered from monoclonal antibodies. Regardless of the upper affinity, GCT02 CAR T cells kill equivalently however secrete decrease quantities of cytokine. As well as, GCT02-CAR T cells additionally mediate fast and full tumor elimination in vivo.
Conclusion: We current a novel EGFRvIII-specific CAR, with efficient antitumor capabilities each in in vitro and in a xenograft mannequin of human glioblastoma.
C13orf3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810301 | ABM | 1.0 ug DNA | EUR 379.2 |
ARL17 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810307 | ABM | 1.0 ug DNA | EUR 379.2 |
HSPC047 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810313 | ABM | 1.0 ug DNA | EUR 379.2 |
C9orf68 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810319 | ABM | 1.0 ug DNA | EUR 379.2 |
C18orf22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810325 | ABM | 1.0 ug DNA | EUR 379.2 |
KIAA0774 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810331 | ABM | 1.0 ug DNA | EUR 379.2 |
BXDC5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810337 | ABM | 1.0 ug DNA | EUR 379.2 |
IL8RA Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810343 | ABM | 1.0 ug DNA | EUR 379.2 |
RBM9 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810349 | ABM | 1.0 ug DNA | EUR 379.2 |
FAM62B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810355 | ABM | 1.0 ug DNA | EUR 379.2 |
BC013798 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810361 | ABM | 1.0 ug DNA | EUR 379.2 |
RTCD1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810367 | ABM | 1.0 ug DNA | EUR 379.2 |
TTC15 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810373 | ABM | 1.0 ug DNA | EUR 379.2 |
RAD51L1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810379 | ABM | 1.0 ug DNA | EUR 379.2 |
TSP50 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810385 | ABM | 1.0 ug DNA | EUR 379.2 |
TMEM22 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810391 | ABM | 1.0 ug DNA | EUR 379.2 |
KTELC1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810397 | ABM | 1.0 ug DNA | EUR 379.2 |
C9orf68 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810403 | ABM | 1.0 ug DNA | EUR 379.2 |
LASS4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810409 | ABM | 1.0 ug DNA | EUR 379.2 |
TMEM49 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810415 | ABM | 1.0 ug DNA | EUR 379.2 |
C2orf24 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810421 | ABM | 1.0 ug DNA | EUR 379.2 |
C1orf62 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810427 | ABM | 1.0 ug DNA | EUR 379.2 |
JMJD5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810433 | ABM | 1.0 ug DNA | EUR 379.2 |
AKD2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810439 | ABM | 1.0 ug DNA | EUR 379.2 |
WDR8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810445 | ABM | 1.0 ug DNA | EUR 379.2 |
LOC90379 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810451 | ABM | 1.0 ug DNA | EUR 379.2 |
SFRS17A Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810457 | ABM | 1.0 ug DNA | EUR 379.2 |
FLJ13052 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810463 | ABM | 1.0 ug DNA | EUR 379.2 |
C6orf182 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810469 | ABM | 1.0 ug DNA | EUR 379.2 |
HNRPK Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810475 | ABM | 1.0 ug DNA | EUR 379.2 |
C20ORF158 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810481 | ABM | 1.0 ug DNA | EUR 379.2 |
PCTK1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810487 | ABM | 1.0 ug DNA | EUR 379.2 |
IGHGA1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810493 | ABM | 1.0 ug DNA | EUR 379.2 |
C8orf41 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810499 | ABM | 1.0 ug DNA | EUR 379.2 |
C19orf61 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810505 | ABM | 1.0 ug DNA | EUR 379.2 |
C10orf33 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810511 | ABM | 1.0 ug DNA | EUR 379.2 |
KIAA1434 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810517 | ABM | 1.0 ug DNA | EUR 379.2 |
LOC23117 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810523 | ABM | 1.0 ug DNA | EUR 379.2 |
C2orf67 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810529 | ABM | 1.0 ug DNA | EUR 379.2 |
MGC10814 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810535 | ABM | 1.0 ug DNA | EUR 379.2 |
BC006419 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810541 | ABM | 1.0 ug DNA | EUR 379.2 |
C21orf122 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810547 | ABM | 1.0 ug DNA | EUR 379.2 |
BC007926 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810553 | ABM | 1.0 ug DNA | EUR 379.2 |
FLJ38668 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810559 | ABM | 1.0 ug DNA | EUR 379.2 |
MGC13008 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810565 | ABM | 1.0 ug DNA | EUR 379.2 |
C12orf62 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810571 | ABM | 1.0 ug DNA | EUR 379.2 |
BC001867 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810577 | ABM | 1.0 ug DNA | EUR 379.2 |
Sep15 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810583 | ABM | 1.0 ug DNA | EUR 379.2 |
C14orf147 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810589 | ABM | 1.0 ug DNA | EUR 379.2 |
MGC12966 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810595 | ABM | 1.0 ug DNA | EUR 379.2 |
LOC113386 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810601 | ABM | 1.0 ug DNA | EUR 379.2 |
LOC80154 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810607 | ABM | 1.0 ug DNA | EUR 379.2 |
LOC100132167 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810613 | ABM | 1.0 ug DNA | EUR 379.2 |
C4orf42 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810619 | ABM | 1.0 ug DNA | EUR 379.2 |
Selk Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810625 | ABM | 1.0 ug DNA | EUR 379.2 |
MGC21881 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810631 | ABM | 1.0 ug DNA | EUR 379.2 |
MGC13057 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810637 | ABM | 1.0 ug DNA | EUR 379.2 |
C18orf20 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810643 | ABM | 1.0 ug DNA | EUR 379.2 |
CXorf50B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810649 | ABM | 1.0 ug DNA | EUR 379.2 |
C13orf36 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810655 | ABM | 1.0 ug DNA | EUR 379.2 |
NDR1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810661 | ABM | 1.0 ug DNA | EUR 379.2 |
C20orf30 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810667 | ABM | 1.0 ug DNA | EUR 379.2 |
C20orf30 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810673 | ABM | 1.0 ug DNA | EUR 379.2 |
Magmas Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810679 | ABM | 1.0 ug DNA | EUR 379.2 |
C6orf168 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810685 | ABM | 1.0 ug DNA | EUR 379.2 |
Dram Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810691 | ABM | 1.0 ug DNA | EUR 379.2 |
FLJ20897 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810697 | ABM | 1.0 ug DNA | EUR 379.2 |
FLJ14107 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810703 | ABM | 1.0 ug DNA | EUR 379.2 |
ZD52F10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810709 | ABM | 1.0 ug DNA | EUR 379.2 |
SEDLP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810715 | ABM | 1.0 ug DNA | EUR 379.2 |
C14orf48 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810721 | ABM | 1.0 ug DNA | EUR 379.2 |
C6orf35 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810727 | ABM | 1.0 ug DNA | EUR 379.2 |
MGC34034 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810733 | ABM | 1.0 ug DNA | EUR 379.2 |
C15ORF15 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810739 | ABM | 1.0 ug DNA | EUR 379.2 |
LOC339047 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810745 | ABM | 1.0 ug DNA | EUR 379.2 |
MGC31957 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810751 | ABM | 1.0 ug DNA | EUR 379.2 |
LOC153328 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810757 | ABM | 1.0 ug DNA | EUR 379.2 |
C3orf34 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810763 | ABM | 1.0 ug DNA | EUR 379.2 |
RANGNRF Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810769 | ABM | 1.0 ug DNA | EUR 379.2 |
RANGNRF Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810775 | ABM | 1.0 ug DNA | EUR 379.2 |
C18orf10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810781 | ABM | 1.0 ug DNA | EUR 379.2 |
NAT13 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810787 | ABM | 1.0 ug DNA | EUR 379.2 |
C9orf61 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810793 | ABM | 1.0 ug DNA | EUR 379.2 |
FKSG24 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810799 | ABM | 1.0 ug DNA | EUR 379.2 |
C3orf60 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810805 | ABM | 1.0 ug DNA | EUR 379.2 |
C2orf7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810811 | ABM | 1.0 ug DNA | EUR 379.2 |
RWDD4A Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810817 | ABM | 1.0 ug DNA | EUR 379.2 |
SAPS3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810823 | ABM | 1.0 ug DNA | EUR 379.2 |
Hdgfrp3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810829 | ABM | 1.0 ug DNA | EUR 379.2 |
MOBKL2B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV810841 | ABM | 1.0 ug DNA | EUR 379.2 |